§ Same category · GLP-1 / metabolic peptides
Mazdutide vs Retatrutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Mazdutide
0
vendors tracked
Retatrutide
0
vendors tracked
Mazdutide
GLP-1/glucagon dual agonist
No current listings at 10mg.
Retatrutide
Triple GCG/GIP/GLP-1 agonist
No current listings at 10mg.
About Mazdutide
A dual GLP-1 and glucagon receptor agonist in late-stage clinical development for obesity, type-2 diabetes, and metabolic-associated fatty liver disease.
About Retatrutide
An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.